MX2010004509A - Formulaciones inyectables de accion prolongada. - Google Patents
Formulaciones inyectables de accion prolongada.Info
- Publication number
- MX2010004509A MX2010004509A MX2010004509A MX2010004509A MX2010004509A MX 2010004509 A MX2010004509 A MX 2010004509A MX 2010004509 A MX2010004509 A MX 2010004509A MX 2010004509 A MX2010004509 A MX 2010004509A MX 2010004509 A MX2010004509 A MX 2010004509A
- Authority
- MX
- Mexico
- Prior art keywords
- long acting
- injectable formulations
- acting injectable
- endoparasites
- animals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Se describen formulaciones inyectables de acción prolongada de lactonas macrocíclicas que comprenden un polímero de poliéster biológicamente aceptable y biodegradable en un sistema solvente para uso en el campo veterinario, especialmente para uso en el combate de ectoparásitos y endoparásitos en animales.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0705822-5A BRPI0705822A2 (pt) | 2007-10-25 | 2007-10-25 | formulação injetável com ação prolongada e uso de um agente semi-sintético derivado do grupo das avermectinas, em combinação com um polìmero biodegradável |
US9501508P | 2008-09-08 | 2008-09-08 | |
PCT/EP2008/064448 WO2009053466A1 (en) | 2007-10-25 | 2008-10-24 | Long acting injectable formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010004509A true MX2010004509A (es) | 2010-05-03 |
Family
ID=40297850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010004509A MX2010004509A (es) | 2007-10-25 | 2008-10-24 | Formulaciones inyectables de accion prolongada. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20110039794A1 (es) |
EP (1) | EP2211839A1 (es) |
AR (1) | AR069033A1 (es) |
AU (1) | AU2008316416A1 (es) |
BR (2) | BRPI0705822A2 (es) |
CA (1) | CA2702800A1 (es) |
MX (1) | MX2010004509A (es) |
NZ (1) | NZ584585A (es) |
WO (1) | WO2009053466A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112014009406A2 (pt) * | 2011-10-18 | 2017-04-18 | Agronomique Inst Nat Rech | uso de derivados de avermectina para aumentar a biodisponibilidade e eficácia de lactonas macrocíclicas |
WO2013142152A1 (en) * | 2012-03-23 | 2013-09-26 | Regents Of The University Of Minnesota | Semi-solid delivery systems |
AR094882A1 (es) * | 2013-02-26 | 2015-09-02 | Zoetis Llc | Selamectina para el tratamiento de las infestaciones por piojos de mar, composición |
US20230310386A1 (en) * | 2020-05-20 | 2023-10-05 | Intervet Inc. | Injectable pharmaceutical compositions and uses thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997011709A1 (en) * | 1995-09-25 | 1997-04-03 | Ashmont Holdings Limited | Anthelmintic macrocyclic lactone compositions |
ES2359973T3 (es) * | 1998-03-19 | 2011-05-30 | MERCK SHARP & DOHME CORP. | Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas. |
SI1063942T1 (en) * | 1998-03-19 | 2004-10-31 | Merck & Co., Inc. | Liquid polymeric compositions for controlled release of bioactive substances |
AUPR602501A0 (en) * | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release pharmaceutical composition |
GB2386067A (en) * | 2002-02-28 | 2003-09-10 | Norbrook Lab Ltd | Long-acting parasiticidal composition with improved bioavailability comprising an avermectin or milbemycin, plus a salicylanilide & a polymeric species |
MXPA05012791A (es) * | 2003-05-25 | 2006-02-22 | Wang Yuwan | Formulacion sostenida que contiene dimeticona. |
US8362086B2 (en) * | 2005-08-19 | 2013-01-29 | Merial Limited | Long acting injectable formulations |
-
2007
- 2007-10-25 BR BRPI0705822-5A patent/BRPI0705822A2/pt not_active Application Discontinuation
-
2008
- 2008-10-24 US US12/739,300 patent/US20110039794A1/en not_active Abandoned
- 2008-10-24 NZ NZ584585A patent/NZ584585A/xx not_active IP Right Cessation
- 2008-10-24 AR ARP080104654A patent/AR069033A1/es not_active Application Discontinuation
- 2008-10-24 AU AU2008316416A patent/AU2008316416A1/en not_active Abandoned
- 2008-10-24 BR BRPI0818258A patent/BRPI0818258A2/pt not_active IP Right Cessation
- 2008-10-24 MX MX2010004509A patent/MX2010004509A/es unknown
- 2008-10-24 CA CA2702800A patent/CA2702800A1/en not_active Abandoned
- 2008-10-24 EP EP08843181A patent/EP2211839A1/en not_active Withdrawn
- 2008-10-24 WO PCT/EP2008/064448 patent/WO2009053466A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
NZ584585A (en) | 2012-08-31 |
WO2009053466A1 (en) | 2009-04-30 |
AR069033A1 (es) | 2009-12-23 |
US20110039794A1 (en) | 2011-02-17 |
BRPI0818258A2 (pt) | 2019-09-24 |
CA2702800A1 (en) | 2009-04-30 |
BRPI0705822A2 (pt) | 2009-06-23 |
AU2008316416A1 (en) | 2009-04-30 |
EP2211839A1 (en) | 2010-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2649340T3 (es) | Administración de fármacos activados por hipoxia y agentes antiangiogénicos para el tratamiento del cáncer | |
CY1119829T1 (el) | Βιοαποικοδομησιμες συνθεσεις απελευθερωσης φαρμακου | |
EP2305214A4 (en) | NEW MOLECULAR ARRANGEMENT, MOLECULAR PROBE FOR MOLECULAR IMAGING AND MOLECULAR PROBE FOR A DRUG DELIVERY SYSTEM, AND MOLECULAR IMAGING SYSTEM AND DRUG DISPENSING SYSTEM | |
MX2009005445A (es) | Sistema de suministro para risperidona. | |
WO2008094834A3 (en) | Multi-functional drug carriers | |
EP2213274A4 (en) | DRUG DELIVERY SYSTEM, AND DRUG DELIVERY DEVICE | |
WO2008002434A3 (en) | Medical devices for release of low solubility therapeutic agents | |
EP2213318A4 (en) | DRUG SOLUTION DELIVERY SYSTEM AND DRUG SOLUTION ADMINISTRATION CANNULA | |
WO2008124735A3 (en) | Multi-functional polyglutamate drug carriers | |
BRPI0818129A2 (pt) | Sistema de transporte e administração de medicamento seguro | |
MX337286B (es) | Formulaciones de transferencia sostenida de compuestos de risperidona. | |
WO2008005176A3 (en) | Electroactive polymer radiopaque marker | |
BRPI0814759A2 (pt) | Sistema de administração e notificação de medicamento específico de paciente | |
MX2010004222A (es) | Formulaciones solidas de compuestos cristalinos. | |
WO2007103666A3 (en) | Implantable medical endoprosthesis delivery systems | |
EA201000747A1 (ru) | Система и способ трансдермальной доставки и способ получения системы трансдермальной доставки | |
HK1172845A1 (en) | Novel pharmaceutical formulations against drug misuse | |
WO2010099292A3 (en) | Biodegradable drug or other active delivery system | |
WO2006097558A3 (es) | Nanopartículas de quitosano y polientilenglicol como sistema de administración de moléculas biológicamente activas | |
GB0817324D0 (en) | Vaginal drug delivery system and method | |
WO2009014827A3 (en) | Medical devices comprising polymeric drug delivery systems with drug solubility gradients | |
MX347056B (es) | Composiciones farmaceuticas. | |
LTPA2019508I1 (lt) | Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui | |
EP2023900A4 (en) | DRUG DELIVERY SYSTEM WITH CONTROLLED DOSES | |
ZA201001418B (en) | Cdh3 pepetide and medicinal agent comprising the same |